UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Studying clonal dynamics in response to cancer therapy using high-complexity barcoding

Nature medicine, 2015-05, Vol.21 (5), p.440-448

2015

Volltextzugriff (PDF)

CuInSe/ZnS Core/Shell NIR Quantum Dots for Biomedical Imaging

Small (Weinheim an der Bergstrasse, Germany), 2011-11, Vol.7 (22), p.3148-3152

2011

Volltextzugriff (PDF)

Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia

Nature genetics, 2013-11, Vol.45 (11), p.1386-1391

2013

Volltextzugriff (PDF)

Degron mediated BRM/SMARCA2 depletion uncovers novel combination partners for treatment of BRG1/SMARCA4-mutant cancers

Biochemical and biophysical research communications, 2019-01, Vol.508 (1), p.109-116

2019

Volltextzugriff (PDF)

Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy

Cell chemical biology, 2023-03, Vol.30 (3), p.235-247.e12

2023

Volltextzugriff (PDF)

Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contexts

Oncogene, 2022-01, Vol.41 (1), p.112-124

2022

Volltextzugriff (PDF)

Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia

Molecular cancer research, 2022-03, Vol.20 (3), p.361-372

2022

Volltextzugriff (PDF)

Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance

Cancer research (Chicago, Ill.), 2023-11, Vol.83 (21), p.3611-3623

2023

Volltextzugriff (PDF)

Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression

Nature medicine, 2011-01, Vol.17 (1), p.123-129

2011

Volltextzugriff (PDF)

The Discovery of SWI/SNF Chromatin Remodeling Activity as a Novel and Targetable Dependency in Uveal Melanoma

Molecular cancer therapeutics, 2020-10, Vol.19 (10), p.2186-2195

2020

Volltextzugriff (PDF)

Effect of Nitroxoline on Angiogenesis and Growth of Human Bladder Cancer

JNCI : Journal of the National Cancer Institute, 2010-12, Vol.102 (24), p.1855-1873

2010

Volltextzugriff (PDF)

ABCG2/BCRP expression modulates D-luciferin-based bioluminescence imaging

Cancer research (Chicago, Ill.), 2007-10, Vol.67 (19), p.9389-9397

2007

Volltextzugriff (PDF)

Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure–activity relationship studies

Bioorganic & medicinal chemistry letters, 2010-01, Vol.20 (1), p.392-397

2010

Volltextzugriff (PDF)

Capmatinib (INC280) Is Active Against Models of Non-Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation

Clinical cancer research, 2019-05, Vol.25 (10), p.3164-3175

2019

Volltextzugriff (PDF)

Cancer imaging: Gene transcription-based imaging and therapeutic systems

The international journal of biochemistry & cell biology, 2012-05, Vol.44 (5), p.684-689

2012

Volltextzugriff (PDF)

In-vivo detection of binary PKA network interactions upon activation of endogenous GPCRs

Scientific reports, 2015-06, Vol.5 (1), p.11133-11133, Article 11133

2015

Volltextzugriff (PDF)

Imaging: CuInSe/ZnS Core/Shell NIR Quantum Dots for Biomedical Imaging (Small 22/2011)

Small (Weinheim an der Bergstrasse, Germany), 2011-11, Vol.7 (22), p.3106-3106

2011

Volltextzugriff (PDF)

Abstract 1025: Controlled and endogenous depletion of a synthetic lethal target in human cancer cell lines via SMASh degron engineering

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1025-1025

2017

Volltextzugriff (PDF)

Abstract 3957: Characterization of functional heterogeneity and in vivo dynamics of clonal cell populations derived from the triple-negative breast cancer cell line MDA-MB-468

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3957-3957

2017

Volltextzugriff (PDF)

Abstract 394: In vivo shRNA screens under treatment pressure by BRAF and MEK inhibitors to identify novel combination treatment strategies for BRAF -mutant colorectal cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.394-394

2019

Volltextzugriff (PDF)

Abstract 3240: Understanding clonal complexity of a tumor xenograft model via cellular barcoding technology

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3240-3240

2015

Volltextzugriff (PDF)

Abstract 2847: High complexity barcoding to study clonal dynamics in response to cancer therapy

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2847-2847

2015

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(22)

Publikationsform

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Studying clonal dynamics in response to cancer therapy using high-complexity barcoding

Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition

Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers

CuInSe/ZnS Core/Shell NIR Quantum Dots for Biomedical Imaging

Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma

Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia

Degron mediated BRM/SMARCA2 depletion uncovers novel combination partners for treatment of BRG1/SMARCA4-mutant cancers

Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy

Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contexts

Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia

Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance

Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression

The Discovery of SWI/SNF Chromatin Remodeling Activity as a Novel and Targetable Dependency in Uveal Melanoma

Effect of Nitroxoline on Angiogenesis and Growth of Human Bladder Cancer

ABCG2/BCRP expression modulates D-luciferin-based bioluminescence imaging

Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure–activity relationship studies

Capmatinib (INC280) Is Active Against Models of Non-Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation

Cancer imaging: Gene transcription-based imaging and therapeutic systems

In-vivo detection of binary PKA network interactions upon activation of endogenous GPCRs

Imaging: CuInSe/ZnS Core/Shell NIR Quantum Dots for Biomedical Imaging (Small 22/2011)

Abstract 1025: Controlled and endogenous depletion of a synthetic lethal target in human cancer cell lines via SMASh degron engineering

Abstract 3957: Characterization of functional heterogeneity and in vivo dynamics of clonal cell populations derived from the triple-negative breast cancer cell line MDA-MB-468

Abstract 394: In vivo shRNA screens under treatment pressure by BRAF and MEK inhibitors to identify novel combination treatment strategies for BRAF -mutant colorectal cancer

Abstract 3240: Understanding clonal complexity of a tumor xenograft model via cellular barcoding technology

Abstract 2847: High complexity barcoding to study clonal dynamics in response to cancer therapy

Suchergebnisse filtern